Bionomics Limited
(ASX:BNO) CEO & Managing Director Deborah Rathjen presents at ASX Spotlight Series Asia.
The company’s presentation is titled, “Creating and developing innovative therapies”.
Ms Rathjen outlines Bionomics’ key financials, business, programs and results, market potential, partnerships, investment highlights and outlook.
